Tocqueville Asset Management L.P. Incyte Corp Transaction History

Tocqueville Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$58.5 - $69.94 $213,525 - $255,281	-3,650 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $17,598 - $21,155	285 Added 8.47%	3,650 $252,000
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $4.06 Million - $5.6 Million	-66,660 Reduced 95.19%	3,365 $225,000
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $28,240 - $34,333	340 Added 0.49%	70,025 $5.84 Million
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $2.4 Million - $2.99 Million	-25,655 Reduced 26.91%	69,685 $6.6 Million
Q3 2017 Oct 30, 2017	BUY	$109.15 - $138.27 $10.4 Million - $13.2 Million	95,340	95,340 $11.1 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.